Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients

1 May 2007

Abstract excerpt

The benefit of postoperative adjuvant chemotherapy in patients with Dukes' B colorectal cancer is still uncertain and its routine use is not recommended. The five-year relapse rate is approximately 25-40% and the identification of patients at high risk of recurrence would represent an important strategy for the use of adjuvant chemotherapy. We retrospectively analyzed gene expression profiles in frozen tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Treatments and Studies
Share to Ferroptosis and cancer prognosis
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17390049
DOI: 10.3892/or.17.5.1089

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patientsPMID 17390049Read ↗

A 19-Gene expression signature as a predictor of survival in colorectal cancerSemantic proximity Read ↗

Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosaSemantic proximity Read ↗

Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancerSemantic proximity Read ↗

Gene expression signature for recurrence in stage III colorectal cancersSemantic proximity Read ↗

Analysis of Gene Expression Profiles Reveals Novel Correlations With the Clinical Course of Colorectal CancerSemantic proximity Read ↗

Identification and validation of a new set of five genes for prediction of risk in early breast cancer.Semantic proximity Read ↗

An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer.Semantic proximity Read ↗

A Seven-Gene Signature Aggregates a Subgroup of Stage II Colon Cancers with Stage IIISemantic proximity Read ↗

Immunoprofiles of 11 Biomarkers Using Tissue Microarrays Identify Prognostic Subgroups in Colorectal CancerSemantic proximity Read ↗

Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancerSemantic proximity Read ↗

Prediction of Response to Preoperative Chemoradiotherapy in Rectal Cancer by Using Reverse Transcriptase Polymerase Chain Reaction Analysis of Four GenesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.